Regeneron Pharmaceuticals, Inc.(NASDAQ : REGN)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||1.03%||68.51||1.0%||$492.03m|
|REGN||Regeneron Pharmaceuticals, Inc.||1.14%||621.40||2.7%||$402.73m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.23%||228.08||1.9%||$340.95m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-3.99%||2.65||0.7%||$185.24m|
|EXAS||EXACT Sciences Corp.||-2.63%||74.03||17.9%||$168.66m|
|ARNA||Arena Pharmaceuticals, Inc.||-0.58%||90.48||13.7%||$131.37m|
|ALNY||Alnylam Pharmaceuticals, Inc.||-1.37%||136.41||8.2%||$125.00m|
|BMRN||BioMarin Pharmaceutical, Inc.||0.24%||84.65||4.2%||$103.18m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.